Cargando…

Epigenetic regulation of cutaneous T-cell lymphoma is mediated by dysregulated lncRNA MALAT1 through modulation of tumor microenvironment

Cutaneous T-Cell Lymphoma (CTCL) is a rare non-Hodgkin lymphoma marked by migration of T-lymphocytes to the skin. It has many subtypes some of which are aggressive with documented metastasis. We investigated a possible role of lncRNA MALAT1 in CTCL cells because of its documented involvement in canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Wei, Liu, Guang-Ming, Guan, Ji-Yu, Chen, Yu-Jia, Zhao, Yang-Zhi, Wang, Kun, Bai, Ou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433805/ https://www.ncbi.nlm.nih.gov/pubmed/36059695 http://dx.doi.org/10.3389/fonc.2022.977266

Ejemplares similares

The Roles of lncRNA in Cutaneous Squamous Cell Carcinoma
por: Wang, Yujia, et al.
Publicado: (2020)

The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer
por: Cusenza, Vincenza Ylenia, et al.
Publicado: (2023)

Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis
por: Tian, Xiaoling, et al.
Publicado: (2015)

Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma
por: Zhang, Ping, et al.
Publicado: (2021)

LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer
por: Song, Zhengwei, et al.
Publicado: (2022)

Genomic Instability-Related LncRNA Signature Predicts the Prognosis and Highlights LINC01614 Is a Tumor Microenvironment-Related Oncogenic lncRNA of Papillary Thyroid Carcinoma
por: Dong, Xubin, et al.
Publicado: (2021)

LncRNA MALAT1 facilitates inflammasome activation via epigenetic suppression of Nrf2 in Parkinson’s disease
por: Cai, Li-Jun, et al.
Publicado: (2020)

Regulatory Networks of LncRNA MALAT-1 in Cancer
por: Fu, Shijian, et al.
Publicado: (2020)

Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
por: Zheng, Miao, et al.
Publicado: (2020)

Effect of LncRNA-MALAT1 on mineralization of dental pulp cells in a high-glucose microenvironment
por: Li, Xinzhu, et al.
Publicado: (2022)

LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2
por: Wang, Xin, et al.
Publicado: (2016)

Epigenetic silencing of E‐cadherin gene induced by lncRNA MALAT‐1 in acute myeloid leukaemia
por: Huang, Jinlong, et al.
Publicado: (2022)

LncRNA MALAT1 Promotes Tumor Angiogenesis by Regulating MicroRNA-150-5p/VEGFA Signaling in Osteosarcoma: In-Vitro and In-Vivo Analyses
por: Vimalraj, Selvaraj, et al.
Publicado: (2021)

LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment
por: Mao, Tsui-Lien, et al.
Publicado: (2021)

Construction of an Immune-Related lncRNA Signature That Predicts Prognosis and Immune Microenvironment in Osteosarcoma Patients
por: He, Yi, et al.
Publicado: (2022)

Associations between LncRNA MALAT1 Polymorphisms and Lymph Node Metastasis in Prostate Cancer
por: Hu, Ju-Chuan, et al.
Publicado: (2021)

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
por: Zhang, Pengpeng, et al.
Publicado: (2023)

A new acidic microenvironment related lncRNA signature predicts the prognosis of liver cancer patients
por: Jiang, Peng, et al.
Publicado: (2022)

Dihydromyricetin induced lncRNA MALAT1-TFEB-dependent autophagic cell death in cutaneous squamous cell carcinoma
por: Tan, Miduo, et al.
Publicado: (2019)

Nuclear-Encoded lncRNA MALAT1 Epigenetically Controls Metabolic Reprogramming in HCC Cells through the Mitophagy Pathway
por: Zhao, Yijing, et al.
Publicado: (2020)

LncRNA MALAT1 Modulates TGF-β1-Induced EMT in Keratinocyte
por: Zhang, Liping, et al.
Publicado: (2021)

Alternative splicing modulation mediated by G-quadruplex structures in MALAT1 lncRNA
por: Ghosh, Arpita, et al.
Publicado: (2021)

The role of LncRNA MALAT-1 and MiRNA-9 in Psoriasis
por: Elamir, Azza M., et al.
Publicado: (2021)

Functions and mechanisms of lncRNA MALAT1 in cancer chemotherapy resistance
por: Hou, Junhui, et al.
Publicado: (2023)

LncRNA MALAT1 knockdown inhibits the development of choroidal neovascularization
por: Zhang, Xiaoli, et al.
Publicado: (2023)

Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
por: Jiang, Zi-Rong, et al.
Publicado: (2022)

Down-regulation of lncRNA MALAT1 alleviates vascular lesion and vascular remodeling of rats with hypertension
por: Xue, Yu-Zeng, et al.
Publicado: (2019)

An Integrated Transcriptomics and Proteomics Analysis Implicates lncRNA MALAT1 in the Regulation of Lipid Metabolism
por: Wang, Hao, et al.
Publicado: (2021)

Novel LncRNA ZFHX4-AS1 as a Potential Prognostic Biomarker That Affects the Immune Microenvironment in Ovarian Cancer
por: Wang, Xiaoyan, et al.
Publicado: (2022)

A necroptosis-related lncRNA signature was identified to predict the prognosis and immune microenvironment of IDH-wild-type GBM
por: Song, Chong, et al.
Publicado: (2022)

Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Ze-Kun, et al.
Publicado: (2022)

Epigenetics of Cutaneous T-Cell Lymphomas
por: Hara, Natsumi, et al.
Publicado: (2022)

LncRNA MALAT1 negatively regulates MDSCs in patients with lung cancer
por: Zhou, Qinfeng, et al.
Publicado: (2018)

LncRNA expression profile during autophagy and Malat1 function in macrophages
por: Ma, Zhanbing, et al.
Publicado: (2019)

The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis
por: Xia, Hongwei, et al.
Publicado: (2016)

EPC‐derived exosomes promote osteoclastogenesis through LncRNA‐MALAT1
por: Cui, Yigong, et al.
Publicado: (2019)

The Role of the lncRNA MALAT1 in Neuroprotection against Hypoxic/Ischemic Injury
por: Wang, Liping, et al.
Publicado: (2022)

Role of lncRNA MALAT1 in UVA-induced corneal endothelial senescence
por: Qiao, Yujie, et al.
Publicado: (2023)

LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer
por: Hao, Longhui, et al.
Publicado: (2023)

LncRNA MALAT1 is dysregulated in diabetic nephropathy and involved in high glucose‐induced podocyte injury via its interplay with β‐catenin
por: Hu, Mengsi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_20ot2tm12tgmu4nk16n4jfs41p